Related Experiment Videos

Differential diagnostic importance of the creatine kinase isoenzyme pattern in severe traumatic head lesions

Klinische Wochenschrift
|September 15, 1980
PubMed

Insights

Acute traumatic brain injuries do not release significant creatine kinase (CK) isoenzymes from the cerebrum. This finding supports the use of CK-MB testing in intensive care to distinguish between skeletal and cardiac muscle damage.

Area of Science:

  • Biochemistry
  • Clinical Chemistry
  • Neurology

Background:

  • Creatine kinase (CK) and its isoenzyme CK-MB are crucial biomarkers.
  • Elevated CK levels can indicate muscle damage, but differentiating the source is vital.
  • Acute traumatic brain injuries present a challenge in interpreting CK levels.

Purpose of the Study:

  • To investigate the release of CK and CK-MB from the cerebrum in patients with acute traumatic brain injuries.
  • To determine if cerebral CK isoenzyme release affects the diagnostic utility of CK-MB in intensive care.

Main Methods:

  • Simultaneous measurement of total CK and CK-MB.
  • Blood samples collected from the internal jugular vein and a cubital vein.
  • Study conducted on 8 patients with acute traumatic cranial lesions.

Main Results:

  • No significant release of CK isoenzymes from the cerebrum was detected.
  • Cerebral contribution to CK levels in jugular venous blood was negligible.
  • CK-MB levels in jugular blood did not significantly differ from peripheral levels.

Conclusions:

  • Acute traumatic cranial lesions do not substantially impact CK isoenzyme levels originating from the brain.
  • CK-MB measurements remain reliable for differentiating between skeletal and cardiac muscle affections in intensive care settings.
  • Cerebral CK release is not a confounding factor in diagnosing myocardial injury post-head trauma.

Related Concept Videos